Leukocyte cell-derived chemotaxin 2 antagonizes MET receptor activation to suppress hepatocellular carcinoma vascular invasion by protein tyrosine phosphatase 1B recruitment.
Chen CK, Yang CY, Hua KT, Ho MC, Johansson G, Jeng YM, Chen CN, Chen MW, Lee WJ, Su JL, Lai TC, Chou CC, Ho BC, Chang CF, Lee PH, Chang KJ, Hsiao M, Lin MT, Kuo ML.
Chen CK, et al. Among authors: lin mt.
Hepatology. 2014 Mar;59(3):974-85. doi: 10.1002/hep.26738. Epub 2014 Jan 16.
Hepatology. 2014.
PMID: 24114941